Company

AltPep

Biotechnology 100 Ne Northlake Way 35 employees

Employees: 35
Contacts: 4
Emails: 4
Phones: 1

www.altpep.com LinkedIn Crunchbase

AltPep Overview

Headquarters: 100 Ne Northlake Way
Website: www.altpep.com
Industry: Biotechnology
Employees: 35
Founded: 2019
Funding: 52.9M

Keywords

Biotechnology Amyloid Disease Alzheimer's Disease

About AltPep

AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.

AltPep Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

AltPep Org Chart

Sample employees and titles

Name	Title	Location	Contact
Chandresh Gajera	In-vivo Biology and Translational Research Using Neurodegenerative Disease Models	San Francisco Bay Area, United States	Email
Gilbert Block	Chief Medical Officer	Haverford, Pennsylvania, United States	Email
Patrik Edenholm		Seattle, Washington, United States	Email
Nancy Hill	Biotechnology Executive of High-growth, Innovation-driven Companies.	Seattle, Washington, United States	Email Phone